The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer

Oncotarget

Volumn 6, Issue 2, 2015, Pages 862-873

  Chen, Anna ^a,b   Wong, Christina S F ^c   Liu, Mira C P ^a   House, Colin M ^a   Sceneay, Jaclyn ^c   Bowtell, David D ^a,b   Thompson, Erik W ^b,d,e   Möller, Andreas ^c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SIAH; TRANSCRIPTION FACTOR ZEB1; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; NUCLEAR PROTEIN; SEVEN IN ABSENTIA PROTEINS; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; ZEB1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN DEGRADATION; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; BREAST TUMOR; CELL LINE; DRUG EFFECTS; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MCF-7 CELLS; MICE; MICROSCOPY, FLUORESCENCE; MODELS, GENETIC; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN-PROTEIN LIGASES;

EID: 84921809977     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2696     Document Type: Article

References (45)

1. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2:442-54.
2. Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005; 24:5764-74.
3. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006; 7:131-42.
4. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008; 68:7846.
5. Comijn J. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Molecular cell. 2001; 7:1267.
6. Dave N, Guaita-Esteruelas S, Gutarra S, Frias A, Beltran M, Peiro S, et al. Functional Cooperation between Snail1 and Twist in the Regulation of ZEB1 Expression during Epithelial to Mesenchymal Transition. J Biol Chem. 2011; 286.
7. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009; 11:1487-U236.
8. Dohadwala M, Yang SC, Luo J, Sharma S, Batra RK, Huang M, et al. Cyclooxygenase-independent regulation of E-cadherin: prostaglandin E2 induces transcriptional repressors ZEB1 and Snail in non-small cell lung cancer. Cancer Res. 2006; 66:5338.
9. Peinado H, Olmeda D, Cano A. Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007; 7:415-28.
10. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004; 117:927-39.
11. Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial-cells to mesenchymal cells-involvement of Type-I receptors. J Cell Biol. 1994; 127:2021-36.
12. Zhou BP. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004; 6:931.
13. Viñas Castells R. The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. J Biol Chem. 2010; 285:3794.
14. Long J. Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin. J Biol Chem. 2005; 280:35477.
15. Lander R, Nordin K, LaBonne C. The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1. The Journal of Cell Biology. 2011; 194:17.
16. House CM, Moller A, Bowtell DDL. Siah Proteins: Novel Drug Targets in the Ras and Hypoxia Pathways. Cancer Res. 2009; 69:8835-8.
17. Wong CSF, Möller A. Siah: A Promising Anticancer Target. Cancer Res. 2013; 73:2400-6.
18. Calzado MA, de la Vega L, Moller A, Bowtell DDL, Schmitz ML. An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat Cell Biol. 2009; 11:85-91.
19. Nakayama K, Qi JF, Ronai Z. The Ubiquitin Ligase Siah2 and the Hypoxia Response. Mol Cancer Res. 2009; 7:443-51.
20. Qi J, Nakayama K, Cardiff RD, Borowsky AD, Kaul K, Williams R, et al. Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors. Cancer Cell. 2010; 18:23-38.
21. Sun Ramon C, Denko Nicholas C. Hypoxic Regulation of Glutamine Metabolism through HIF1 and SIAH2 Supports Lipid Synthesis that Is Necessary for Tumor Growth. Cell Metabolism. 2014; 19:285-92.
22. Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J, et al. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol. 2008; 10:812-24.
23. Ahmed AU, Schmidt RL, Park CH, Reed NR, Hesse SE, Thomas CF, et al. Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth. Journal of the National Cancer Institute. 2008; 100:1606.
24. Möller A, House CM, Wong CSF, Scanlon DB, Liu MCP, Ronai Z, et al. Inhibition of Siah ubiquitin ligase function. Oncogene. 2009; 28:289-96.
25. Fiucci G, Beaucourt S, Duflaut D, Lespagnol A, Stumptner-Cuvelette P, Géant A, et al. Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101:3510-5.
26. Roperch J-P, Lethrone F, Prieur S, Piouffre L, Israeli D, Tuynder M, et al. SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: Identification of common effectors with p53 and p21Waf1. Proceedings of the National Academy of Sciences. 1999; 96:8070-3.
27. Jumpertz S, Hennes T, Asare Y, Vervoorts J, Bernhagen J, Schütz AK. The β-catenin E3 ubiquitin ligase SIAH-1 is regulated by CSN5/JAB1 in CRC cells. Cellular Signalling. 2014; 26:2051-9.
28. Leung CON, Deng W, Ye T-M, Ngan HYS, Tsao SW, Cheung ANY, et al. miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway. Carcinogenesis. 2014.
29. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, et al. Siah-1 Mediates a Novel β-Catenin Degradation Pathway Linking p53 to the Adenomatous Polyposis Coli Protein. Molecular cell. 2001; 7:927-36.
30. Matsuzawa S-I, Reed JC. Siah-1, SIP, and Ebi Collaborate in a Novel Pathway for =-Catenin Degradation Linked to p53 Responses. Molecular cell. 2001; 7:915-26.
31. Wang D, Wang Y, Kong T, Fan F, Jiang Y. Hypoxia-induced β-catenin downregulation involves p53-dependent activation of Siah-1. Cancer Science. 2011; 102:1322-8.
32. Yoshibayashi, Okabe, Satoh, Hida, Kawashima, Hamasu, et al. SIAH1 causes growth arrest and apoptosis in hepatoma cells through β-catenin degradation-dependent and-independent mechanisms. Oncology Reports. 2007; 17:549-56.
33. House CM, Hancock NC, Moller A, Cromer BA, Fedorov V, Bowtell DDL, et al. Elucidation of the substrate binding site of Siah ubiquitin ligase. Structure. 2006; 14:695-701.
34. Wong CSF, Sceneay J, House CM, Halse HM, Liu MCP, George J, et al. Vascular Normalization by Loss of Siah2 Results in Increased Chemotherapeutic Efficacy. Cancer Res. 2012; 72:1694-704.
35. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration. J Biol Chem. 2000; 275:36803-10.
36. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. p38 mitogen-activated protein kinase is required for TGF β-mediated fibroblastic transdifferentiation and cell migration. Journal of Cell Science. 2002; 115: 3193-206.
37. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nature Genet. 2001; 29:117-29.
38. Nadeau RJ. Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2. Journal of cellular biochemistry. 2007; 100:151.
39. Nakayama K, Frew IJ, Hagensen M, Skals M, Habelhah H, Bhoumik A, et al. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1 alpha abundance, and modulates physiological responses to hypoxia. Cell. 2004; 117:941-52.
40. Qi J, Kim H, Scortegagna M, Ronai ZE. Regulators and Effectors of Siah Ubiquitin Ligases. Cell Biochem Biophys. 2013:1-10.
41. Della NG. Isolation and characterisation of murine homologues of the Drosophila seven in absentia gene (sina). Journal of embryology and experimental morphology. 1993; 117:1333.
42. Frew IJ, Hammond VE, Dickins RA, Quinn JMW, Walkley CR, Sims NA, et al. Generation and analysis of Siah2 mutant mice. Mol Cell Biol. 2003; 23:9150-61.
43. Hugo HJ, Kokkinos MI, Blick T, Ackland ML, Thompson EW, Newgreen DF. Defining the E-Cadherin Repressor Interactome in Epithelial-Mesenchymal Transition: The PMC42 Model as a Case Study. Cells Tissues Organs. 2011; 193:23-40.
44. Dickins RA, Frew IJ, House CM, O'Bryan MK, Holloway AJ, Haviv I, et al. The Ubiquitin Ligase Component Siah1a Is Required for Completion of Meiosis I in Male Mice. Mol Cell Biol. 2002; 22:2294-303.
45. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Meth. 2012; 9:671-5.